Skip to main content

Gene Therapy Market Analysis 2018-2025: Key Findings, Regional Analysis, Key Players Profiles and Future Prospects

Press release   •   Apr 29, 2019 10:32 IST

The gene therapy market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The growth of the gene therapy market is regulated due to various reason which includes the rapid involvement of synthetically modified gene to treat various diseases, it helps in designing the personalized medicine, rise in the research and development of the gene therapy among the others. The gene therapy requires less doses of medicines and is one time treatment, this factor is likely to show growth opportunity for gene therapy market in coming near future. 

Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPHE100001165/

North America is anticipated to dominate the gene therapy market in the global scenario owing to various factors such as reimbursement services, technological developments in the biotechnology industry and increasing research activities. Europe is the second largest market for the gene therapy as the various innovation are being done in this region. In 2016, European Union approved Zalmoxis for the treatment of leukemia. Asia Pacific is the fastest growing region as the studies are taking rapid pace for the biotechnological industry and increase in cardiovascular disease.. Owing to these factors the market are likely to propel the growth of the market for gene therapy market in coming future.

Leading Players: 

1. Sangamo Therapeutics, Inc.
2. bluebird bio, Inc.
3. uniQure N.V.
4. AveXis, Inc.
5. Vineti
6. Solid Biosciences.
7. Spark Therapeutics, Inc.
8. CHIMERON BIO
9. RENOVA THERAPEUTICS
10. HORAMA S.A.

Gene therapy is introduction of DNA into a patient to treat a genetic disease or a disorder. The newly inserted DNA contains a correcting gene to correct the effects of disease causing mutations. Gene therapy is promising treatment for the genetic diseases and also includes cystic fibrosis and muscular dystrophy. Gene therapy is suitable treatment for the infectious diseases, inherited disease and cancer.

Inquire for discount: https://www.theinsightpartners.com/discount/TIPHE100001165/

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global gene therapy market based on cell type, and application. It also provides market size and forecast till 2025 for overall gene therapy market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.  

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.